Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/46730
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Engur-Ozturk, Selin | - |
dc.contributor.author | Dikmen, Miris | - |
dc.date.accessioned | 2023-01-09T21:15:54Z | - |
dc.date.available | 2023-01-09T21:15:54Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 0301-4851 | - |
dc.identifier.issn | 1573-4978 | - |
dc.identifier.uri | https://doi.org/10.1007/s11033-022-07329-w | - |
dc.identifier.uri | https://hdl.handle.net/11499/46730 | - |
dc.description.abstract | Background Lung cancer is a leading cause of cancer-related deaths, primarily as a result of metastases. In this metastasis, the epithelial-to-mesenchymal transition (EMT) is essential. Interaction with the cancer cell microenvironment is primarily dependent on M1- and M2-polarized macrophage. Methods and results In this study, we revealed the EMT-associated activity of M1, M2a and M2c macrophages in A549 lung cancer cells. We established a co-culture model of A549 lung cancer cells utilizing THP-1-derived M1/M2 polarised macrophages to explore the involvement of macrophages in the immune response, apoptosis, and EMT in lung cancer. Although multiple polarising agents are routinely used for M1 and M2 conversion, we assessed a new possible polarising agent, hydrocortisone. Conclusions M1 increased A549 cell sensitivity to proteasome inhibitors and decreased A549 cell viability by inducing apoptosis. EMT was induced in the presence of M2c macrophages in A549 cells by the levels of vimentin, fibronectin, E-cadherin, NF-kB, CCL-17. We also revealed the antiproliferative effects of bortezomib and ixazomib on A549 cells in both 2D and 3D cultures. Our findings could help develop an immunotherapeutic strategy by shedding light on a previously undiscovered part of the EMT pathway. Furthermore, additional investigation may reveal that polarising tumour-associated macrophages to M1 and eliminating the M2a or particularly the M2c subtype are effective anti-cancer strategies. | en_US |
dc.description.sponsorship | Anadolu University Scientific Research Projects [1704S095] | en_US |
dc.description.sponsorship | This study was funded by Anadolu University Scientific Research Projects (grant number 1704S095.). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Molecular Biology Reports | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | A549 | en_US |
dc.subject | Macrophages | en_US |
dc.subject | EMT | en_US |
dc.subject | NF-kB | en_US |
dc.subject | Bortezomib | en_US |
dc.subject | Ixazomib | en_US |
dc.subject | Alternative Activation | en_US |
dc.subject | Tumor-Growth | en_US |
dc.subject | Kappa-B | en_US |
dc.subject | Metastasis | en_US |
dc.subject | Mln2238 | en_US |
dc.subject | Marker | en_US |
dc.subject | Emt | en_US |
dc.title | Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 49 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 4777 | en_US |
dc.identifier.endpage | 4793 | en_US |
dc.authorid | Engur Ozturk, Selin/0000-0003-1534-8117 | - |
dc.identifier.doi | 10.1007/s11033-022-07329-w | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57226403029 | - |
dc.authorscopusid | 14026554000 | - |
dc.identifier.pmid | 35279785 | en_US |
dc.identifier.scopus | 2-s2.0-85126148913 | en_US |
dc.identifier.wos | WOS:000768120100001 | en_US |
local.message.claim | 2023-07-10T21:26:44.214+0300|||rp01402|||submit_approve|||dc_contributor_author|||None | * |
dc.identifier.scopusquality | Q2 | - |
item.languageiso639-1 | en | - |
item.fulltext | With Fulltext | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | open | - |
crisitem.author.dept | 37.01. Pharmacy Services | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tavas Sağlık Hizmetleri Meslek Yüksekokulu Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
s11033-022-07329-w.pdf | 9.49 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
5
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
7
checked on Oct 20, 2024
Page view(s)
30
checked on Aug 24, 2024
Download(s)
80
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.